Native Remedies
Calendar
Category Archives: Natural Treatment For Depression:
Gene research offers hope for treating depression
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Bookmark to:
Depression sometimes shifts to bipolar disorder
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
Jan. 21, 2012
Antidepressant use soaring among Americans 12 and over
Dec. 7, 2011
Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Bookmark to:
Transcranial magnetic stimulation offers hope treating depression
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Bookmark to:
Transcranial magnetic stimulation can treat depression
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Bookmark to:
Keep fighting even when depression treatments don’t work
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
New antidepressant offers hope
Sept. 3, 2011
Sorting out the evidence for antidepressants
July 22, 2011
Perseverance can pay off in finding right antidepressant
June 17, 2011
Why do antidepressants stop working?
May 6, 2011
Connect with others who’ve been there.Share stories. Learn. Join Mayo Clinic’s
online community. Free E-Newsletters
Subscribe to receive the latest updates on health topics. About our newsletters
HousecallAlzheimer’s caregiving Living with cancer
View the Original article
Bookmark to:
